61.88 F
New York
October 21, 2020

Home » Pfizer Inc

Pfizer Inc

CNBC Business

Dr. Scott Gottlieb: U.S. is in the 7th inning of the pandemic but the ‘hardest part’ is likely ahead

CNBC
by CNBC028
CNBC – For more and to sign up click here Dr. Scott Gottlieb: ‘Hardest part’ of coronavirus outbreak is ahead Search quotes, news & videos Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Dr. Scott Gottlieb dismisses inaccurate take on CDC data cited by Trump to question Covid masks

CNBC
by CNBC018
CNBC – For more and to sign up click here Dr. Scott Gottlieb on inaccurate take on CDC mask data cited by Trump...
Read more
CNBC Business

States face Friday deadline from CDC to submit plans to distribute coronavirus vaccine

CNBC
by CNBC035
...
Read more
CNBC Business

Stocks making the biggest moves premarket: Pfizer, Boeing, Chewy.com, Caterpillar & more

CNBC
by CNBC012
...
Read more
CNBC Business

Stocks making the biggest moves premarket: Walgreens, Morgan Stanley, Fastly, Wells Fargo & more

CNBC
by CNBC016
CNBC – For more and to sign up click here Stocks making the biggest moves premarket: Walgreens, Morgan Stanley, Fastly, Wells Fargo & more Search quotes, news & videos Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Dr. Scott Gottlieb: Antibody drugs may be helpful virus treatments, but won’t end U.S. epidemic

CNBC
by CNBC018
CNBC – For more and to sign up click here Dr. Scott Gottlieb: Coronavirus antibody drugs won’t end U.S. epidemic SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Gilead CEO: ‘We have ample supply’ of remdesivir for hospitalized coronavirus patients

CNBC
by CNBC043
CNBC – For more and to sign up click here Gilead Sciences will have sufficient global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O’Day told CNBC on Friday.  The comments come shortly after the publication of peer-reviewed final data from Gilead’s large-scale trial of remdesivir. It......
Read more
CNBC Business

HHS Secretary Azar says U.S. could have enough coronavirus vaccine doses for every American by March

CNBC
by CNBC039
CNBC – For more and to sign up click here Alex Azar, secretary of Health and Human Services (HHS), wears a protective mask during a House Select Subcommittee on the Coronavirus Crisis hearing in Washington, D.C., U.S., on Friday, Oct. 2, 2020. Azar is appearing before the committee to testify......
Read more
CNBC Business

‘Raging epidemic is not inevitable’ — Dr. Scott Gottlieb believes China case count and rips U.S. response

CNBC
by CNBC04
CNBC – For more and to sign up click here Dr. Scott Gottlieb on Monday lamented the persistent spread of the coronavirus in the U.S., suggesting the nation’s response pales in comparison to other places around the world. “The entire Pacific Rim has less than 1,000 infections a day. Having......
Read more
CNBC Business

Ex-Trump FDA chief criticizes White House over coronavirus precautions to protect Trump and staff

CNBC
by CNBC023
CNBC – For more and to sign up click here Scott Gottlieb hits White House over Trump coronavirus precautions...
Read more
CNBC Business

Pfizer CEO says U.S. presidential debate was ‘disappointing’ in memo to employees that criticizes politicizing coronavirus vaccine process

CNBC
by CNBC095
CNBC – For more and to sign up click here Pfizer CEO Albert Bourla sent a memo to employees Thursday criticizing this week’s U.S. presidential debate as “disappointing,” saying the political rhetoric surrounding the outbreak and vaccine development is “undercutting public confidence.” “Once more, I was disappointed that the prevention......
Read more
CNBC Business

Coronavirus vaccine trial participants report day-long exhaustion, fever and headaches — but say it’s worth it

CNBC
by CNBC032
CNBC – For more and to sign up click here Coronavirus vaccine trial participants: Exhaustion, fever, headaches SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

The Trump-Biden debate helped the stock market go higher, Jim Cramer says

CNBC
by CNBC018
...
Read more
CNBC Business

Why so many people are hopeful about an mRNA coronavirus vaccine

CNBC
by CNBC029
CNBC – For more and to sign up click here Why so many people are hopeful about an mRNA coronavirus vaccine SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Sanofi isn’t cutting corners in coronavirus vaccine development despite acceleration, CEO says

CNBC
by CNBC035
CNBC – For more and to sign up click here Sanofi CEO Paul Hudson on coroanvirus vaccine development timeline SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Top U.S. health officials try to reassure people of coronavirus vaccine safety as concerns stir

CNBC
by CNBC029
CNBC – For more and to sign up click here Top U.S. health officials tout coronavirus vaccine safety as concerns stir SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Fauci tells Congress the U.S. could have enough coronavirus vaccine doses for every American by April

CNBC
by CNBC08
CNBC – For more and to sign up click here Coronavirus vaccine: Fauci tells Congress the U.S. could have enough for every American by April SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

AstraZeneca coronavirus vaccine trial remains on hold in the U.S., HHS chief Azar says

CNBC
by CNBC058
CNBC – For more and to sign up click here AstraZeneca‘s late-stage coronavirus vaccine trial in the U.S. remains on hold as federal investigators seek “answers to important questions” over its safety for patients, Health and Human Services Secretary Alex Azar told CNBC on Wednesday.   Global clinical trials for AstraZeneca’s Covid-19......
Read more
CNBC Business

Stocks making the biggest moves in the premarket: Nike, General Mills, J&J, KKR, KB Home & more

CNBC
by CNBC019
CNBC – For more and to sign up click here Stocks making the biggest moves in the premarket: Nike, General Mills, J&J, KKR, KB Home & more SEARCH QUOTES Source – Click here for more To Return to the Main Aggregate News Page – click here...
Read more
CNBC Business

Johnson & Johnson enters late-stage trial testing its coronavirus vaccine

CNBC
by CNBC065
CNBC – For more and to sign up click here Johnson & Johnson has begun its phase three trial testing its potential coronavirus vaccine, the pharmaceutical company announced Wednesday. J&J is the fourth drugmaker backed by the Trump administration’s Covid-19 vaccine program Operation Warp Speed to enter late-stage testing. The other......
Read more

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More